Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-20
DOI
10.3389/fphar.2021.626010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
- (2021) Claudia Calpe-López et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats
- (2020) Yasaman Razavi et al. BEHAVIOURAL PHARMACOLOGY
- Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats
- (2020) José Pedro Prieto et al. NEUROTOXICITY RESEARCH
- Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction
- (2020) Jasper A. Heinsbroek et al. Cold Spring Harbor Perspectives in Medicine
- Endocannabinoid System Components as Potential Biomarkers in Psychiatry
- (2020) Francisco Navarrete et al. Frontiers in Psychiatry
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
- (2020) Emilio Perucca et al. CNS DRUGS
- Treatment of stimulant use disorder: A systematic review of reviews
- (2020) Claire Ronsley et al. PLoS One
- The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
- (2020) Miguel Á. Luján et al. Frontiers in Behavioral Neuroscience
- Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
- (2020) Dvora Izgelov et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
- (2020) Éamon Jones et al. MOLECULES
- Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
- (2020) Umberto Raucci et al. Frontiers in Pharmacology
- Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
- (2020) Ani Gasparyan et al. Neurotherapeutics
- Cannabidiol (CBD) reduces cocaine-environment memory in mice
- (2020) Rose Chesworth et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Increasing potency and price of cannabis in Europe, 2006-16
- (2019) Tom P. Freeman et al. ADDICTION
- A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
- (2019) Nadia Solowij et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment
- (2019) Ester Aso et al. MOLECULAR NEUROBIOLOGY
- New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
- (2019) Suman Chandra et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review
- (2019) Jasmine Turna et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats
- (2019) Saeideh Karimi-Haghighi et al. ADDICTION BIOLOGY
- Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
- (2019) Adrián Viudez-Martínez et al. ADDICTION BIOLOGY
- Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
- (2019) Yasmin L. Hurd et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity
- (2019) Matthew B Wall et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake
- (2019) Miguel Ángel Luján et al. ADDICTION BIOLOGY
- Nabiximols for the Treatment of Cannabis Dependence
- (2019) Nicholas Lintzeris et al. JAMA Internal Medicine
- Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
- (2019) Julia De Ternay et al. Frontiers in Pharmacology
- Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus Through Bi-Directional Control of ERK1-2 Phosphorylation
- (2019) Roger Hudson et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-TH1A and TRPV1 receptor mechanisms
- (2019) Ewa Galaj et al. NEUROPHARMACOLOGY
- How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
- (2019) Abigail M. Freeman et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The loss of NMDAR‐dependent LTD following cannabinoid self‐administration is restored by positive allosteric modulation of CB1 receptors
- (2019) Daniela Neuhofer et al. ADDICTION BIOLOGY
- Cannabidiol does not display drug abuse potential in mice behavior
- (2018) Adrián Viudez-Martínez et al. ACTA PHARMACOLOGICA SINICA
- Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
- (2018) Chandni Hindocha et al. ADDICTION
- Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
- (2018) Anjali K. Bhardwaj et al. BMC Psychiatry
- Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice
- (2018) Alyssa M Myers et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal
- (2018) Francisco Navarrete et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
- (2018) Adrián Viudez-Martínez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Depleting adult dentate gyrus neurogenesis increases cocaine-seeking behavior
- (2018) Véronique Deroche-Gamonet et al. MOLECULAR PSYCHIATRY
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
- (2018) Gustavo Gonzalez-Cuevas et al. NEUROPSYCHOPHARMACOLOGY
- Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial
- (2018) Jose M. Trigo et al. PLoS One
- Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats
- (2018) Saeideh Karimi-Haghighi et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers
- (2018) C. Hindocha et al. Scientific Reports
- Role of the endocannabinoid system in drug addiction
- (2018) Jorge Manzanares et al. BIOCHEMICAL PHARMACOLOGY
- Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
- (2018) David Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
- (2018) Gracie L Hay et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Max G Griswold et al. LANCET
- Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
- (2018) Miguel Ángel Luján et al. NEUROPHARMACOLOGY
- Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice
- (2018) Rocio Saravia et al. BRAIN BEHAVIOR AND IMMUNITY
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances
- (2018) Helle Wessel Andersson et al. ADDICTIVE BEHAVIORS
- Pharmacotherapy of alcoholism – an update on approved and off-label medications
- (2017) Michael Soyka et al. EXPERT OPINION ON PHARMACOTHERAPY
- The endocannabinoid system as a target for addiction treatment: Trials and tribulations
- (2017) Matthew E. Sloan et al. NEUROPHARMACOLOGY
- The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal
- (2017) Christina A Brezing et al. NEUROPSYCHOPHARMACOLOGY
- A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
- (2017) Ashleigh L. Osborne et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice
- (2017) James Markos et al. PLANTA MEDICA
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
- (2017) Sabrina Giacoppo et al. Multiple Sclerosis and Related Disorders
- Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
- (2017) Yuping Wang et al. Scientific Reports
- Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats
- (2016) Cristiane Ribeiro de Carvalho et al. ADDICTION BIOLOGY
- Psychiatric, Demographic, and Brain Morphological Predictors of Relapse After Treatment for an Alcohol Use Disorder
- (2016) Timothy C. Durazzo et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III
- (2016) Deborah S. Hasin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Therapeutic Potential of Cannabinoids in Psychosis
- (2016) F. Markus Leweke et al. BIOLOGICAL PSYCHIATRY
- Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: results from compulsorily and voluntarily admitted patients
- (2016) Adrian R. Pasareanu et al. BMC HEALTH SERVICES RESEARCH
- Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
- (2016) Jose M. Trigo et al. DRUG AND ALCOHOL DEPENDENCE
- Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence
- (2016) Jose M. Trigo et al. Journal of Addiction Medicine
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- (2016) F Patti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
- (2016) Justine Renard et al. JOURNAL OF NEUROSCIENCE
- Sex differences, gender and addiction
- (2016) Jill B. Becker et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats
- (2016) Ashraf Mahmud et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
- (2016) Christopher Norris et al. NEUROPSYCHOPHARMACOLOGY
- A place for the hippocampus in the cocaine addiction circuit: Potential roles for adult hippocampal neurogenesis
- (2016) Estela Castilla-Ortega et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabis sativa: The Plant of the Thousand and One Molecules
- (2016) Christelle M. Andre et al. Frontiers in Plant Science
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
- (2016) Fernanda F. Peres et al. Frontiers in Pharmacology
- Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
- (2016) Rose A. Rudd et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- (2015) Lucy Burns et al. ADDICTION
- The Nucleus Accumbens: An Interface Between Cognition, Emotion, and Action
- (2015) Stan B. Floresco Annual Review of Psychology
- The role of serotonin in drug use and addiction
- (2015) Christian P. Müller et al. BEHAVIOURAL BRAIN RESEARCH
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal
- (2015) DJ Allsop et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The dopamine theory of addiction: 40 years of highs and lows
- (2015) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Endocannabinoid signalling in reward and addiction
- (2015) Loren H. Parsons et al. NATURE REVIEWS NEUROSCIENCE
- 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking
- (2015) In-Jee You et al. NEUROPSYCHOPHARMACOLOGY
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release
- (2015) Pedro H. Gobira et al. NEUROTOXICOLOGY
- Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction
- (2015) Aile N. van Huijstee et al. Frontiers in Cellular Neuroscience
- Long-Term Course of Opioid Addiction
- (2015) Yih-Ing Hser et al. HARVARD REVIEW OF PSYCHIATRY
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies
- (2014) Xiaofan Li et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- (2014) Lili Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- (2013) Yih-Ing Hser et al. ADDICTION
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
- (2013) M Jerry Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation
- (2013) P Trifilieff et al. MOLECULAR PSYCHIATRY
- Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
- (2013) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
- (2013) Daniel J. Liput et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
- (2013) Raymond J. M. Niesink et al. Frontiers in Psychiatry
- Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1Areceptors in the dorsal raphe nucleus
- (2012) Vicky Katsidoni et al. ADDICTION BIOLOGY
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- Pharmacological maintenance treatments of opiate addiction
- (2012) James Bell BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
- (2012) Ryan Vandrey et al. DRUG AND ALCOHOL DEPENDENCE
- Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders
- (2012) R. Andrew Chambers DRUG AND ALCOHOL DEPENDENCE
- Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report
- (2012) J. A. S. Crippa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
- (2012) Alline Cristina Campos et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery
- (2012) Chitra D. Mandyam et al. TRENDS IN NEUROSCIENCES
- The endocannabinoid system: a key modulator of emotions and cognition
- (2012) Patrizia Campolongo et al. Frontiers in Behavioral Neuroscience
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice
- (2011) Auxiliadora Aracil-Fernández et al. ADDICTION BIOLOGY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diagnostic criteria for cannabis withdrawal syndrome
- (2011) David A. Gorelick et al. DRUG AND ALCOHOL DEPENDENCE
- Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
- (2011) Philip Robson Expert Opinion On Drug Safety
- A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
- (2011) Kerri Alexandra Schoedel et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Mesocorticolimbic Glutamatergic Pathway
- (2011) T. Yamaguchi et al. JOURNAL OF NEUROSCIENCE
- The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
- (2011) Eva M Marco et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
- (2011) Eric Murillo-Rodríguez et al. LIFE SCIENCES
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- New Findings on Biological Factors Predicting Addiction Relapse Vulnerability
- (2011) Rajita Sinha Current Psychiatry Reports
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
- (2011) Eva Marco Frontiers in Behavioral Neuroscience
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- (2010) Susanne A Wolf et al. Cell Communication and Signaling
- Role of Serotonin in Central Dopamine Dysfunction
- (2010) Giuseppe Di Giovanni et al. CNS Neuroscience & Therapeutics
- Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers
- (2010) Kenneth H. Levin et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological characterization of GPR55, a putative cannabinoid receptor
- (2010) Haleli Sharir et al. PHARMACOLOGY & THERAPEUTICS
- Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates
- (2010) M. A. Taffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cocaine on adult hippocampal neurogenesis in an animal model of differential propensity to drug abuse
- (2009) M. J. GarcÃa-Fuster et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- Neurocircuitry of Addiction
- (2009) George F Koob et al. NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system in brain reward processes
- (2008) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
- (2008) Robert E. Vann et al. DRUG AND ALCOHOL DEPENDENCE
- Chronic voluntary ethanol intake hypersensitizes 5-HT1Aautoreceptors in C57BL/6J mice
- (2008) Sabah Kelaï et al. JOURNAL OF NEUROCHEMISTRY
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid
- (2007) P. Massi et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started